By
Drug Target Review2025-08-08T08:30:21
A new study from the Van Andel Institute shows that glucose not only fuels T cells but also strengthens their internal signalling and cancer-fighting capabilities –offering a potential route to improved immunotherapies.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-04-15T09:36:00Z
2024-01-19T07:40:55
Sponsored by Euretos
2025-05-08T10:38:52
Sponsored by Takara Bio USA
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2023-03-20T13:41:33
Sponsored by Bio-Techne
Site powered by Webvision Cloud